戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ections - gastrointestinal nematodes (GINs), liver flukes, and lungworms - and the search for subclin
2 significant advances in our understanding of liver fluke biology have been made through in-depth inte
3 eef cattle, but it is unclear at what levels liver fluke burdens cause production losses.
4  early immature and adult Fasciola hepatica (liver fluke) but widespread resistance to the drug great
5  praziquantel decreases the risk of CCA from liver flukes, but reinfection is common and future vacci
6 t closely related to CsRn1 from the Oriental liver fluke Clonorchis sinensis and to kabuki from Bomby
7       It has been established that the Asian liver flukes, Clonorchis sinensis and Opisthorchis viver
8 l estimated that cattle classified as having liver fluke damage had on average 10 days greater slaugh
9           Only marginal activity against the liver fluke Fasciola hepatica and Trichostrongylus colub
10                                          The liver fluke Fasciola hepatica is a major pathogen of liv
11  and an emerging human disease caused by the liver fluke Fasciola hepatica.
12 rganisation of gene expression in the common liver fluke, Fasciola hepatica.
13                      For instance, the giant liver fluke, Fascioloides magna, is a major parasite of
14 sease, roundworm, whipworm, pinworm, Chinese liver fluke, fleas and lice.
15 /Cas9 knockout of the Ov-GRN-1 gene from the liver fluke genome.
16 he role of the secreted growth factor termed liver fluke granulin (Ov-GRN-1) in pre-malignant lesions
17 RISPR gene knockout (KO) demonstrated that a liver fluke growth mediator contributes to disease progr
18 igated for associations among infection with liver fluke, Helicobacter and hepatobiliary fibrosis.
19 nomic and gene-editing tools to the study of liver fluke immunobiology and pathogenesis has accelerat
20 odel of infection and a tissue microarray of liver fluke-induced human cholangiocarcinomas (CCAs).
21 ovel antibody serodiagnostic tests for human liver fluke infection and associated cancer.
22  proteome to identity antibody biomarkers of liver fluke infection and CCA with sera from study parti
23                                      Chronic liver fluke infection induces a distinct mutational land
24                                              Liver fluke infection is a major risk for cholangiocarci
25 cinoma are poorly understood, though chronic liver fluke infection is a risk factor for disease.
26                          In endemic regions, liver fluke infection is associated with CCA, owing to t
27 se uncertainties by estimating the impact of liver fluke infection on UK beef cattle productivity and
28 ss screening in northeastern Thailand, where liver fluke infection rates are particularly severe; how
29 ablishment of treatment guidelines for human liver fluke infection.
30  of currently registered drugs against human liver fluke infection.
31                                              Liver fluke infections occur in people worldwide.
32 nce, and the prospects for future control of liver fluke infections using an integrated parasite mana
33 oidiasis - in addition to the intestinal and liver fluke infections, as some of the most important ga
34                    Fasciola hepatica, common liver fluke, infects cattle and sheep causing disease an
35 his felineus, a bile duct-dwelling trematode liver fluke is highly endemic.
36 evelopments are encouraging a renaissance in liver fluke neurobiology that can now support flukicide
37 trols, 293 and 260 positive and negative for liver fluke O. viverrini eggs, of residents in Northeast
38 versally effective, lacking activity against liver flukes of the Fasciola genus.
39 links between parasitism by the carcinogenic liver fluke Opisthorchis viverrini and this coregulator
40                                          The liver fluke Opisthorchis viverrini infects 10 million pe
41             Transmission of the carcinogenic liver fluke Opisthorchis viverrini is ongoing across Sou
42                Infection with the food-borne liver fluke Opisthorchis viverrini is the principal risk
43                                          The liver fluke Opisthorchis viverrini resides within the bi
44                                          The liver fluke Opisthorchis viverrini, highly prevalent in
45 hologue of granulin from the human parasitic liver fluke Opisthorchis viverrini, known as Ov-GRN-1, i
46 en cholangiocarcinoma and infection with the liver fluke Opisthorchis viverrini.
47  CCA, and there is a direct correlation with liver fluke (Opisthorchis viverrini) infection.
48 cal disease caused by the carcinogenic Asian liver fluke, Opisthorchis viverrini.
49 the excretory-secretory products (ES) of the liver fluke parasite Fasciola hepatica as cargo of extra
50 iated with substantial morbidity and several liver fluke species are recognised as biological carcino
51  felineus are the three most important human liver fluke species in the Opisthorchiidae family, infec
52 hter age by weight and different measures of liver fluke status, while accounting for sex, breed, sea
53           Here, we examined the functions of liver fluke tetraspanins, four-transmembrane domain prot
54 nology technologies to discover that elusive liver fluke vaccine.
55 matical model to assess the effectiveness of liver fluke vaccines under simulated field conditions.